Buy Perjeta (Pertuzumab)

What is Perjeta (pertuzumab) for?

Buy Perjeta (Pertuzumab). Perjeta (pertuzumab) is used to treat HER2 positive breast cancer. It helps patients with metastatic cancer or as a first step before surgery for early-stage cancer.

How does Perjeta (pertuzumab) work?

Perjeta works with other medicines to fight HER2-positive breast cancer. It’s used for patients who haven’t had other treatments yet.

It’s also used before surgery for HER2-positive breast cancer. This is for patients with early-stage or locally advanced cancer.

 

Is Perjeta (pertuzumab) approved?

Yes, Perjeta is approved for HER2 positive breast cancer. It was approved by:

• FDA (USA) on June 12, 2012
• EMA (EU) on March 4, 2013
• TGA (AUS) on May 6, 2013
• Health Canada on May 8, 2013
• Medsafe (New Zealand) on July 18, 2013

How do I take Perjeta (pertuzumab)?

The usual dose is:

• First dose: 840 mg as a 60-minute IV infusion
• Next doses: 420 mg as a 30 to 60-minute IV infusion every 3 weeks.

For metastatic breast cancer, keep taking Perjeta and trastuzumab until the disease gets worse or side effects are too much.

In neoadjuvant treatment, get Perjeta every 3 weeks for 3 to 6 cycles before surgery.

For more details on dosage and how to take Perjeta, see the references section.

Note: Always talk to your doctor about your specific treatment plan.

Common side effects of Perjeta (pertuzumab)

Common side effects with Perjeta and chemotherapy include:

• diarrhoea
• alopecia (hair loss)
• nausea
• neutropenia (low neutrophils, important for fighting infections).

Serious side effects of Perjeta (pertuzumab)

Common serious side effects are:

• febrile neutropenia (low neutrophils with fever)
• serious diarrhoea
• leucopenia (low white blood cell counts)
• neutropenia.

Buy Opdivo (Nivolumab)